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1. Introduction 
Studies on citrate synthases from a wide range of 
bacteria have revealed various inhibition and activa- 
tion effects which may be correlated with the metab- 
olic capabilities of the different organisms [ 1,2]. To 
complement investigations of naturally-occurring 
citrate synthase variants we have begun to study artifi- 
cially-generated mutant forms of the enzyme [3,5] . 
The strategy was first to generate citrate synthase- 
deficient (CS-) mutants and then, by reversion, to 
regain the enzymic activity. If the revertant enzymes 
had an altered amino acid sequence, compared with 
that of the original enzyme, then changes in molec- 
ular and regulatory properties might result. 
In the course of this work a new procedure for the 
isolation of CS- mutants was devised. This relies on 
the lethal effect of fluoroacetate which is believed 
to be exerted after its conversion, via citrate synthase, 
to fluorocitrate [6]. Mutants devoid of citrate syn- 
thase cannot produce fluorocitrate and may, as a 
result, be resistant to the toxic effect of fluoroace- 
tate. 
2. Experimental 
Four strains of Escherichia coli K12 (Kl.1, K2.1, 
AB 259 and AB 1621) and three CS- mutants derived 
therefrom (Kl.1.4, K2.1.4 and AB 1623) were kindly 
provided by Professor Sir Hans Komberg, University 
of Cambridge. A CS-mutant of AB 259 was isolated 
as below.dcinefobacter calcouceticus, strain 4B, was 
isolated by P. D. J. W. from water. Methods of 
growth in liquid or on solid media were as in [5]. 
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Mutagenesis was carried out with ethylmethane 
sulphonate as in [7]. In the case of E. coli AB 259 
penicillin enrichment was performed by the double- 
cycle procedure [8]. A mutated culture was first 
grown in minimal medium containing 10 mM succi- 
nate and 1 mM glutamate, washed and transferred to 
medium containing 10 mM succinate only and treated 
with ampicillin (20 pg/ml) for 1 h at 37°C. The 
cells were then transferred and allowed to grow in 
succinate-glutamate medium and the procedure 
repeated. The resulting culture was serially diluted 
and plated onto nutrient-agar plates. Plates with 
-100 colonies were replicated onto succinate and 
succinate-glutamate plates and mutants elected 
which grew on the latter but not on succinate alone. 
These were grown in liquid culture and cell-free 
extracts were tested for citrate synthase activity. 
By this procedure, aCS mutant of E. coli AB 259, 
designated AB 259-CS1, was isolated. 
Selection for resistance to fluoroacetate was per- 
formed as follows. A culture of Acinetobacter calco- 
aceticus was mutated as above, transferred to 100 ml 
minimal medium containing 10 mM glutamate and 
1 mM fluoroacetate and grown to stationary phase. 
The culture was then diluted and plated onto 
glutamate-fluoroacetate plates at -100 cells/plate 
and incubated at 30°C for 3 days. 
Citrate synthase was assayed spectrophotometri- 
tally at 412 nm and 25°C as in [9]. 
3. Results and discussion 
The extreme toxicity of fluoroacetate isbelieved 
to depend on its metabolic onversion to fluoroci- 
tram by the same reactions as would metabolise ace- 
tate itself. Activation to fluoroacetyl-CoA may occur 
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either by the action of acetate thiokinase or by the 
joint action of acetate kinase and phosphotrans- 
acetylase. The fluoroacetyl-CoA may then act as a 
substrate for citrate synthase, generating fluorocitrate 
which, in many organisms, is a powerful inhibitor 
of aconitase and thus blocks the citric acid cycle [6]. 
On this basis’organisms devoid of citrate synthase, 
and hence unable to produce fluorocitrate, might be 
immune to the toxic effect of fluoroacetate. Citrate 
synthase deficiency would also result in the inability 
to synthesise cw-oxoglutarate and this might be com- 
pensated for by providing glutamate in the growth 
medium. This anticipated resistance to fluoroacetate 
was first tested using several CS-mutants of E. coli 
and their wild-type parental strains. When spread on 
agar plates containing 10 mM succinate, 1 mM gluta- 
mate and 1 mM fluoroacetate, the wild-type strains of 
E. coli (KM, K2.1, AB 259 and AB 1621) failed com- 
pletely to grow. However, the CS- mutants derived 
from these strains (Kl.1.4, K2.1.4, AB 259-CSl and 
AI3 1623) all grew on this medium thereby demon- 
strating their resistance to fluoroacetate. We therefore 
tried the direct method of fluoroacetate resistance 
to obtain CS- mutants of Acinetobacter calcoaceti- 
cus, whose insensitivity to penicillin made the muta- 
genesis/penicillin enrichment procedure ineffective. 
The procedure in section 2 was employed and a 
large number of mutants were obtained which grew 
on the glutamate-fluoroacetate medium. From these, 
mutants were selected for their ability to grow on 
glutamate but their inability to grow on either acetate 
or succinate, and analysis of cell-free extracts showed 
that several had virtually zero levels of citrate syn- 
thase. Consistent with the absence of this enzyme 
was a growth requirement for glutamate, ooxoglutar- 
ate or proline. We have used such CS- mutants to 
obtain revertant CS’ strains either spontaneously 
or after mutagenesis [lo] or by transformation 
[4]. The method of fluoroacetate resistance therefore 
does succeed in selecting CS- mutants and should, in 
principle, be applicable to a range of other organisms 
(both prokaryotic and eukaryotic) and should prove 
a useful additional approach complementing methods 
which have been applied by other investigators. 
Bacterial mutants devoid of citrate synthase have 
been isolated and studied by other workers. CS- 
mutants were isolated from E. coli W and Aerobacfer 
aerogenes after mutation by W irradiation followed 
by penicillin enrichment and selection for glutamate 
auxotrophs [ 111 and a CS- mutant of E. coli K12 
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was isolated by mutagenesis with N-methyl-N’nitro- 
N-nitrosoguanidine followed by selection for gluta- 
mate auxot rophs [ 121. A mutant of Pseudomonas 
aeruginosa largely deficient in citrate synthase was 
isolated by mutagenesis and selection for inability 
to grow on acetate [13]. A range of citric acid cycle 
mutants of Bacillus subtilis was isolated by heating 
spores, then plating them out on nutrient-agar con- 
taining calcium carbonate [14]. Mutants lacking en- 
zymes of the citric acid cycle accumulated organic 
acids and this led to the formation of halos around 
mutant colonies, resulting from solubilization of the 
calcium carbonate. Among the mutants so isolated 
were some deficient in citrate synthase. In [15], CS- 
mutants of E. coli K12 were isolated as double mu- 
tants also lacking isocitrate dehydrogenase. Mutants 
of E. coli lacking isocitrate dehydrogenase grew very 
slowly on medium containing glucose plus glutamate 
but were overgrown by other mutants found, addi- 
tionally, to lack citrate synthase [ 151. It was sug- 
gested that isocitrate dehydrogenase-deficient mu- 
tants produce a build-up of citrate or isocitrate which 
is inhibitory to growth; the CS- mutants cannot 
produce such an accumulation and thereby avoid 
growth inhibition [ 151. 
Resistance to fluoroacetate has been used [16,17] 
to isolate mutants of E. coli lacking acetate kinase or 
phosphotransacetylase. Resistance to fluoroacetate 
and fluoroacetamide has also been used [ 18,19 ] to 
obtain mutants of Aspergillus nidulans, while resis- 
tance to fluoroacetamide has been used [20]to 
isolate mutants of Pseudomonas aeruginosa defec- 
tive in the structural or regulator genes for amidase. 
To our knowledge there have been no published 
reports on the use of fluoroacetate to isolate CS- 
mutants. Following our report on mutant citrate syn- 
thases from A. calcoaceticus [4], which referred to 
the isolation of CS- strains by selection for fluoroace- 
tate resistance, we learned that J. T. Beatty and H. 
Gest (personal communication) have employed a 
similar procedure to isolate CS- mutants from Rho- 
dopseudomonas capsulata. 
In applying this procedure to other organisms it 
must be borne in mind that an immunity to the effect 
of fluoroacetate may be conferred by a variety of 
mechanisms. Mutations other than in citrate synthase 
may prevent the generation of fluorocitrate, and 
there may also be an inability to take up fluoroace- 
tate into the cell. In other cases citrate synthase may 
not utilise fluoroacetyl-CoA as effectively as acetyl- 
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CoA [21] or the aconitase may be relatively insensi- 
tive to fluorocitrate inhibition [22,23]. Ano.ther pos- 
sibility is that the organism may be able to hydrolyse 
fluoroacetate to glycollate (e.g. Pseudomonads) and 
hence escape its toxicity. Nevertheless it is likely that 
a considerable number of organisms will yield CS- 
mutants by the fluoroacetate selection procedure. 
Finally, although the effect of fluorocitrate has 
been ascribed to its inhibition of aconitase, the sup- 
pression of growth may not be due simply to block- 
ing of the citric acid cycle at this step, since the pres- 
ence of glutamate in the growth medium (e.g., with 
wild-type E. coli) did not overcome the toxic effect 
of fluoroacetate. It may be that the inhibition of 
aconitase leads to an accumulation of citrate and/or 
fluorocitrate, and that these latter compounds inhibit 
other cellular functions [24,25]. 
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